Yes, prime editing can potentially be used for cancer therapy. By correcting oncogenic mutations or restoring the function of tumor suppressor genes, prime editing can directly target the genetic basis of cancer. Additionally, this technology can be employed to engineer immune cells, such as CAR-T cells, to enhance their ability to recognize and destroy cancer cells. This approach could lead to highly personalized and effective treatments.
